Which statement best defines an Adverse Event (AE) in a clinical trial?

Which statement best defines an Adverse Event (AE) in a clinical trial?

• A. An untoward medical occurrence in a subject administered a medicinal product, which may or may not be related to the product.
• B. An allergic reaction that is definitely caused by the drug.
• C. A routine change in study protocol.
• D. A positive therapeutic outcome.

Answer: (A)

An Adverse Event is any untoward medical occurrence in a subject who has received a medicinal product, which may or may not be related to the product. This means it covers a wide range of happenings—from headaches and rashes to new medical diagnoses or lab abnormalities—that occur after drug exposure, regardless of whether the cause is known or proven to be the drug. If investigators believe there is a causal link, it’s called an adverse drug reaction; if there isn’t a clear link, it’s still recorded as an AE. The other statements aren’t correct because a protocol change isn’t an event in a participant, and a positive therapeutic outcome isn’t something unwanted or harmful.

An Adverse Event is any untoward medical occurrence in a subject who has received a medicinal product, which may or may not be related to the product. This means it covers a wide range of happenings—from headaches and rashes to new medical diagnoses or lab abnormalities—that occur after drug exposure, regardless of whether the cause is known or proven to be the drug. If investigators believe there is a causal link, it’s called an adverse drug reaction; if there isn’t a clear link, it’s still recorded as an AE. The other statements aren’t correct because a protocol change isn’t an event in a participant, and a positive therapeutic outcome isn’t something unwanted or harmful.